Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News TCT 2017

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

Todd Neale

November 09, 2017

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Four

Shelley Wood

November 02, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

Presentation TCT 2017

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

Presenter: Daniel Burkhoff, Samir R. Kapadia, Patrick Klein

November 01, 2017

$My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!$

Presentation TCT 2017

My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!

Presenter: Timothy D. Henry, Marc S. Penn

October 31, 2017

Presentation TCT 2017

Critical Limb Ischemia Update, and the STOP-PAD Trial

Presenter: Timothy D. Henry, Marc S. Penn, Mehdi H. Shishehbor

October 31, 2017

Presentation TCT 2017

New Strategies: Repetitive Injections

Presenter: Timothy D. Henry, Marc S. Penn, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

New Trials: REGENT-VSEL

Presenter: Timothy D. Henry, Marc S. Penn, Wojtek Wojakowski

October 31, 2017

Presentation TCT 2017

Factors Affecting Evaluation for Ischemic Heart Disease and Cath Lab Referral

Presenter: Alice K. Jacobs, Spencer B. King III

October 31, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

Slovenia Presents: MitraClip in Severe Ischemic Heart Disease - Hybrid Treatment Approach

Presenter: Emmanouil I Skalidis, Matjaz Bunc

October 31, 2017

Presentation TCT 2017

Transcatheter Left Ventricular Reconstruction for Treatment of Post-Myocardial Infarction Ischemic Cardiomyopathy

Presenter: Vasilis Babaliaros, Shmuel Banai, Andrew Wechsler

October 30, 2017

Presentation TCT 2017

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Presenter: Sripal Bangalore, Manesh R. Patel, David J. Maron

October 30, 2017

Presentation TCT 2017

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Presenter: Sripal Bangalore, Manesh R. Patel, Carlo Di Mario

October 30, 2017

Presentation TCT 2017

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

Presenter: Sripal Bangalore, Manesh R. Patel, Adhir Shroff

October 30, 2017

Presentation TCT 2017

The Inflammatory Hypothesis After CANTOS: CIRT

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Advertisement

Experts Debate: Should Cerebral Protection Be Used for All TAVRs?

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Live From Denver: TCT 2017, Day Four

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Preliminary Results of Hybrid, Less-Invasive Left Ventricular Reshaping for Ischemic Cardiomyopathy the St. Antonius Hospital Experience

My Belief: Cell Therapy for Refractory Ischemia Is Ready for Daily Practice!

Critical Limb Ischemia Update, and the STOP-PAD Trial

New Strategies: Repetitive Injections

New Trials: REGENT-VSEL

Factors Affecting Evaluation for Ischemic Heart Disease and Cath Lab Referral

Long-term Absorb BVS Data Continue to Disappoint

Slovenia Presents: MitraClip in Severe Ischemic Heart Disease - Hybrid Treatment Approach

Transcatheter Left Ventricular Reconstruction for Treatment of Post-Myocardial Infarction Ischemic Cardiomyopathy

Case Resolution: A Patient With Stable Angina Our Approach and Outcome

Revascularization in Stable Ischemic Heart Disease: What Do the US Guidelines and AUC Say?

Revascularization in Stable Ischemic Heart Disease: What Do the Data and EU Guidelines Say?

Case Introduction: A Patient With Stable Angina How Should We Evaluate and Treat?

The Inflammatory Hypothesis After CANTOS: CIRT

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content